60
Participants
Start Date
May 29, 2024
Primary Completion Date
May 29, 2024
Study Completion Date
December 10, 2024
Specific immunotherapy (SIT) treatment
Treatment with subcutaneous polymerized 100 specific immunotherapy (SIT) in its initiation phase with rapid (clustered) dosing, where the highest allergen concentration (0.2 + 0.3 mL) is administered directly, with an interval of 30 to 45 minutes between injections, in allergology consultations of the SES.
Dietary Supplement: ABB C1
"Ingredients: betaglucanos, levadura Saccharomyces cerevisiae, selenio y zinc.~1 sachet/day; contains 3 grams"
Mini-tablets with pork extract
Mini-tablets with pork extract containing the diamine oxidase enzyme (3 mini-tablets/day)
GALA Laboratories, Don Benito
Lead Sponsor
Gala Servicios Clinicos S.L.
OTHER